Effects of Oral Vitamin B1 and Mecobalamin on Dry Eye Disease
Table 4
The correlations between pre- and posttreatment signs/symptoms/treatment satisfaction scores and sex/age.
G1
G2
G3
G4
Estimate (sex)
Estimate (age)
Estimate (sex)
Estimate (age)
Estimate (sex)
Estimate (age)
Estimate (sex)
Estimate (age)
Signs
TMH
Ns
ns
0.056
ns
ns
ns
ns
ns
TBUTF
Ns
ns
ns
−0.029
0.719
−0.025
ns
ns
TBUTA
ns
ns
ns
ns
ns
−0.034
ns
ns
Symptoms
Dryness
ns
ns
ns
−0.065
−1.892
ns
−2.182
ns
Pain
ns
−0.060
ns
−0.891
ns
ns
ns
−0.083
Burning
ns
ns
ns
ns
ns
−0.048
−2.072
ns
Watering
ns
ns
ns
ns
ns
ns
−2.734
ns
Asthenopia
ns
ns
ns
−0.085
ns
ns
ns
−0.054
Blurred vision
ns
ns
1.820
ns
ns
ns
ns
0.069
Itching
ns
ns
ns
ns
2.012
−0.091
−2.636
ns
Photophobia
ns
ns
2.736
ns
−2.969
ns
−3.873
0.054
Total
ns
ns
ns
ns
ns
−0.346
−26.519
ns
Satisfaction
Before
ns
ns
ns
ns
ns
0.030
−1.579
−0.113
After
ns
ns
ns
ns
ns
−0.049
3.627
−0.055
After-before
ns
ns
ns
ns
ns
−0.082
ns
ns
Following advice
−2.223
ns
0.951
ns
ns
ns
−0.019
0.003
Improvement
ns
ns
ns
ns
ns
ns
ns
−0.136
G1: group 1; G2: group 2; G3: group 3; G4: group 4; TMH: tear meniscus height; TBUTF: tear film breakup time first; TBUTA: tear film breakup time average; Satisfaction: before: pretreatment satisfaction with ocular surface; after: posttreatment satisfaction with ocular surface; following advice: compliance with the doctor's advice; improvement: satisfaction with therapeutic effects. ns: no statistical significance.
